| Primary |
| Product Used For Unknown Indication |
30.7% |
| Drug Use For Unknown Indication |
28.4% |
| Schizophrenia |
12.9% |
| Insomnia |
4.0% |
| Parkinson's Disease |
3.7% |
| Parkinsonism |
2.5% |
| Bipolar I Disorder |
1.8% |
| Depression |
1.7% |
| Intentional Overdose |
1.6% |
| Constipation |
1.5% |
| Suicide Attempt |
1.5% |
| Epilepsy |
1.4% |
| Schizophrenia, Paranoid Type |
1.4% |
| Hypertension |
1.2% |
| Intentional Self-injury |
1.2% |
| Self Injurious Behaviour |
1.0% |
| Dementia |
0.9% |
| Extrapyramidal Disorder |
0.9% |
| Mania |
0.9% |
| Hallucination, Auditory |
0.8% |
|
| Neuroleptic Malignant Syndrome |
17.8% |
| Delirium |
7.9% |
| Urinary Retention |
7.9% |
| Tremor |
6.9% |
| Rhabdomyolysis |
5.9% |
| Somnolence |
5.0% |
| Hepatitis Acute |
4.0% |
| Pulmonary Embolism |
4.0% |
| Pyrexia |
4.0% |
| Restlessness |
4.0% |
| Status Epilepticus |
4.0% |
| Thrombocytopenia |
4.0% |
| Visual Impairment |
4.0% |
| Confusional State |
3.0% |
| Depressed Level Of Consciousness |
3.0% |
| Drug Ineffective |
3.0% |
| Drug Interaction |
3.0% |
| Hallucination |
3.0% |
| Memory Impairment |
3.0% |
| Overdose |
3.0% |
|
| Secondary |
| Product Used For Unknown Indication |
29.6% |
| Drug Use For Unknown Indication |
24.2% |
| Schizophrenia |
13.9% |
| Depression |
4.7% |
| Bipolar I Disorder |
3.8% |
| Schizophrenia, Paranoid Type |
3.6% |
| Parkinson's Disease |
3.4% |
| Parkinsonism |
3.3% |
| Insomnia |
1.7% |
| Self Injurious Behaviour |
1.7% |
| Constipation |
1.4% |
| Anxiety |
1.3% |
| Psychotic Disorder |
1.2% |
| Delirium |
1.1% |
| Suicide Attempt |
1.0% |
| Heart Transplant |
0.9% |
| Acute Psychosis |
0.8% |
| Delusion |
0.8% |
| Hypertension |
0.8% |
| Drug Exposure During Pregnancy |
0.7% |
|
| Delirium |
11.6% |
| Self Injurious Behaviour |
11.6% |
| Restlessness |
8.9% |
| Tremor |
8.9% |
| Tachycardia |
8.0% |
| Urinary Retention |
6.2% |
| Suicide Attempt |
4.9% |
| Somnolence |
4.4% |
| Pyrexia |
4.0% |
| Thrombocytopenia |
4.0% |
| Myopathy |
3.6% |
| Urinary Incontinence |
3.6% |
| Ileus |
3.1% |
| Neurogenic Bladder |
3.1% |
| Neuroleptic Malignant Syndrome |
2.7% |
| Psychotic Disorder |
2.7% |
| Altered State Of Consciousness |
2.2% |
| Hypertension |
2.2% |
| Hyponatraemia |
2.2% |
| Pneumonia |
2.2% |
|
| Concomitant |
| Schizophrenia |
31.0% |
| Drug Use For Unknown Indication |
12.5% |
| Product Used For Unknown Indication |
11.8% |
| Depression |
6.2% |
| Insomnia |
4.6% |
| Schizophrenia, Paranoid Type |
4.4% |
| Parkinson's Disease |
3.2% |
| Psychotic Disorder |
2.8% |
| Bipolar Disorder |
2.7% |
| Extrapyramidal Disorder |
2.7% |
| Constipation |
2.6% |
| Parkinsonism |
2.5% |
| Hypertension |
2.5% |
| Anxiety |
1.8% |
| Hiv Infection |
1.7% |
| Prophylaxis |
1.6% |
| Schizoaffective Disorder |
1.4% |
| Hallucination |
1.4% |
| Bipolar I Disorder |
1.3% |
| Major Depression |
1.2% |
|
| Schizophrenia |
8.5% |
| Weight Increased |
8.5% |
| Vomiting |
8.3% |
| Tremor |
6.4% |
| Suicide Attempt |
6.2% |
| White Blood Cell Count Increased |
5.9% |
| Somnolence |
5.7% |
| Thrombocytopenia |
4.7% |
| Neuroleptic Malignant Syndrome |
4.5% |
| Pulmonary Embolism |
4.3% |
| Death |
4.0% |
| Rhabdomyolysis |
4.0% |
| Sudden Death |
4.0% |
| White Blood Cell Count Decreased |
4.0% |
| Pneumonia |
3.8% |
| Tachycardia |
3.8% |
| Overdose |
3.6% |
| Fall |
3.3% |
| Sepsis |
3.3% |
| Hepatic Function Abnormal |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
33.3% |
| Drug Use For Unknown Indication |
11.5% |
| Neuropathy Peripheral |
9.2% |
| Schizophrenia |
8.0% |
| Anorexia Nervosa |
6.9% |
| Bipolar Disorder |
4.6% |
| Bipolar I Disorder |
3.4% |
| Mania |
3.4% |
| Parkinson's Disease |
3.4% |
| Dystonia |
2.3% |
| Hypertension |
2.3% |
| Sleep Disorder |
2.3% |
| Alcohol Withdrawal Syndrome |
1.1% |
| Cardiac Failure |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
| Dementia |
1.1% |
| Depression |
1.1% |
| Neuralgia |
1.1% |
| Pain |
1.1% |
| Polydipsia Psychogenic |
1.1% |
|
| Drug Interaction |
29.0% |
| Supraventricular Extrasystoles |
19.4% |
| Inappropriate Antidiuretic Hormone Secretion |
6.5% |
| Weight Increased |
6.5% |
| Aspiration |
3.2% |
| Aspiration Bronchial |
3.2% |
| Insomnia |
3.2% |
| Parkinsonism |
3.2% |
| Respiratory Tract Infection Bacterial |
3.2% |
| Screaming |
3.2% |
| Speech Disorder |
3.2% |
| Status Epilepticus |
3.2% |
| Thinking Abnormal |
3.2% |
| Thirst |
3.2% |
| Unresponsive To Stimuli |
3.2% |
| Visual Impairment |
3.2% |
|
